3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial
Author:
- B AnderssonBAB Andersson
- 1 April 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9110) , 1180-1181
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)The American Journal of Cardiology, 1997
- Changes in Early and Late Diastolic Filling Patterns Induced by Long-term Adrenergic β-Blockade in Patients With Idiopathic Dilated CardiomyopathyCirculation, 1996
- Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled studyJACC, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure: A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprololEuropean Heart Journal, 1993